Package | dk.kip.rkkp.fhir.ig.core |
Type | ValueSet |
Id | ATCImmunotherapyCLL |
FHIR Version | R4 |
Source | https://kip.rkkp.dk/fhir/https://build.fhir.org/ig/KIP-infrastructure/implementation-guide/ValueSet-ATCImmunotherapyCLL.html |
URL | https://kip.rkkp.dk/fhir/ValueSet/ATCImmunotherapyCLL |
Version | 2.12.0 |
Status | active |
Date | 2022-07-13T00:00:00+02:00 |
Name | ATCImmunotherapyCLL |
Title | ATC_CLL_immunterapi |
Description | ATC koder immunterapi - [CLL] |
No resources found
CodeSystem | |
ATC | WHO ATC |
GenericValues | Generic values |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet ATCImmunotherapyCLL
This value set includes codes based on the following rules:
https://kip.rkkp.dk/fhir/CodeSystem/GenericValues
Code | Display | Definition |
none | Ingen immunterapi | None - used to choose none of the available values |
other | Andet | Other - used to choose unspecific value not in a valueset |
https://kip.rkkp.dk/fhir/CodeSystem/ATC
Code | Display | Definition |
L04AA34 | Alemtuzumab | L04AA34 - alemtuzumab |
L01FA01 | Rituximab | L01FA01 - rituximab |
L01FA02 | Ofatumumab | L01FA02 - ofatumumab |
L01FA03 | Obinutuzumab | L01FA03 - obinutuzumab |
{ "resourceType": "ValueSet", "id": "ATCImmunotherapyCLL", "text": { "status": "extensions", "div": "<!-- snip (see above) -->" }, "url": "https://kip.rkkp.dk/fhir/ValueSet/ATCImmunotherapyCLL", "version": "2.12.0", "name": "ATCImmunotherapyCLL", "title": "ATC_CLL_immunterapi", "status": "active", "experimental": true, "date": "2022-07-13T00:00:00+02:00", "publisher": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S", "contact": [ { "name": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S", "telecom": [ { "system": "url", "value": "https://trifork.com" }, { "system": "email", "value": "rbk@trifork.com" } ] } ], "description": "ATC koder immunterapi - [CLL]", "compose": { "include": [ { "system": "https://kip.rkkp.dk/fhir/CodeSystem/GenericValues", "concept": [ { "code": "none", "display": "Ingen immunterapi" }, { "code": "other", "display": "Andet" } ] }, { "system": "https://kip.rkkp.dk/fhir/CodeSystem/ATC", "concept": [ { "code": "L04AA34", "display": "Alemtuzumab" }, { "code": "L01FA01", "display": "Rituximab" }, { "code": "L01FA02", "display": "Ofatumumab" }, { "code": "L01FA03", "display": "Obinutuzumab" } ] } ] } }